Skip to main content
logo
Seres Therapeutics, Inc. (MCRB)
NASDAQ: MCRB · Real-Time Price · USD
4.480
-0.240 (-5.08%)
At close: Aug 13, 2026, 4:00 PM EDT
4.450
-0.030 (-0.67%)
After-hours: Aug 13, 2026, 7:34 PM EDT

Seres Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1.880.79---144.93
Revenue Growth
-----336.33%
Gross Profit
1.880.79---144.93
Selling, General & Admin
32.1539.1653.1877.577.569.26
Research & Development
46.6449.0664.6117.6117.6141.89
Other Operating Expenses
7.146.543.53---1.73
Total Operating Expenses
85.9294.76121.32195.1195.1209.42
Operating Income
-84.03-93.97-121.32-195.1-195.1-64.49
Interest Income
1.572.233.977.37.32.87
Interest Expense
----2.47-2.47-2.91
Other Non-Operating Income (Expense)
57.597.44-8.420.130.13-1.05
Total Non-Operating Income (Expense)
59.0799.67-4.464.974.97-1.09
Pretax Income
-24.965.7-125.77-190.13-190.13-65.58
Net Income
-7.135.7-125.77-190.13-190.13-65.58
Earnings From Discontinued Operations
--125.9176.4176.41-
Net Income to Common
-15.335.70.14-113.72-113.72-65.58
Net Income Growth
-4088.24%----
Shares Outstanding (Basic)
998655
Shares Outstanding (Diluted)
998655
Shares Change
10.96%14.16%21.40%18.44%17.86%14.93%
EPS (Basic)
-2.440.64--17.77-46.20-14.40
EPS (Diluted)
-2.440.64--17.77-46.20-14.40
EPS Growth
------
Free Cash Flow
-51.30.87-148.99-125.33-238.64-2.88
Free Cash Flow Growth
------
Free Cash Flow Per Share
-5.490.10-19.18-19.58-44.16-0.63
Gross Margin
100.00%100.00%---100.00%
Operating Margin
-4462.77%-11910.10%----44.50%
Profit Margin
-378.70%721.93%----45.25%
FCF Margin
-2724.11%109.63%----1.99%
EBITDA
-80.59-89.84-115.85-188.85-188.47-58.55
EBITDA Margin
-4279.61%-11386.30%----40.40%
EBIT
-84.03-93.97-121.32-195.1-195.1-64.49
EBIT Margin
-4462.77%-11910.10%----44.50%
SEC Filings: 10-K · 10-Q